Retatrutide Pen 20mg

About Retatrutide Pen

Retatrutide in a pre-filled 3 mL research cartridge — the triple agonist at the GLP-1, GIP and glucagon receptors.

Retatrutide is a synthetic peptide that acts as an agonist at three receptors simultaneously — GLP-1, GIP and glucagon — which distinguishes it from the dual and single agonists that preceded it. The glucagon arm is the element most often isolated in the literature, since it introduces an energy-expenditure component alongside the appetite and insulin-secretion pathways of the other two.

This is the same compound supplied in REVIVE's lyophilised vials, presented instead in a pre-filled cartridge already in solution.

Research mechanism

Research interest centres on:

• GLP-1 receptor agonism — insulin secretion and gastric emptying pathways
• GIP receptor agonism — incretin signalling studied alongside the GLP-1 arm
• Glucagon receptor agonism — hepatic glucose output and energy expenditure
• Combined triple-receptor pharmacology in metabolic study models